Withdrawal of Notice Regarding the Food and Drug Administration Drug Review Timeline Transparency; Revocation of Statement of Policy

Summary

The Department of Health and Human Services and the Food and Drug Administration are withdrawing a notice and revoking a policy statement regarding the transparency of their review timeline for drug applications, citing that the original notice did not consider all publicly available information about the review process.